Ochratoxin study [2]

International Journal of Cancer

Volumn 112, Issue 6, 2004, Pages 1083-

  Castegnaro, Marcel ^a   Bartsch, Helmut ^b,d   Tillmann, Thomas ^c   Mohr, Ulrich ^d  

^a Deutsches Krebsforschungszentrum ^*

^b FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCHRATOXIN; CARCINOGEN;

CARCINOGENICITY; KIDNEY CANCER; LETTER; PRIORITY JOURNAL; ANIMAL; CHEMICALLY INDUCED DISORDER; DNA ADDUCT; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; KIDNEY TUMOR; LEWIS RAT; NOTE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PUBLISHING; RAT; RAT STRAIN; SPECIES DIFFERENCE; STANDARD;

ADMINISTRATION, ORAL; ANIMALS; CARCINOGENS; DNA ADDUCTS; FEMALE; JOURNALISM, MEDICAL; KIDNEY NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; OCHRATOXINS; ORGAN SIZE; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; SPECIES SPECIFICITY;

EID: 8644272603     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20508     Document Type: Letter

References (2)

1. Son W-C, Kamino K, Lee Y-S. Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats. Int J Cancer 2003;105:305-11.
2. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Estève J, Steinmann J, Tillmann T, Michelon J, Azemar B, Bartsch H. Strain- and sex-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int J Cancer 1998;77:70-5.